WGS
USDGeneDx Holdings Corp. Class A Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$134.910
Máximo
$141.750
Mínimo
$134.000
Volume
0.68M
Fundamentos da empresa
Capitalização de mercado
4.0B
Setor
Diagnostics & Research
País
United States
Estatísticas de negociação
Volume médio
0.58M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Raises Price Target to $140
Wells Fargo analyst Brandon Couillard maintains GeneDx Holdings with a Equal-Weight and raises the price target from $95 to $140.
Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $160
Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings with a Buy and raises the price target from $155 to $160.
Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $170
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings with a Buy and raises the price target from $115 to $170.
BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $165
BTIG analyst Mark Massaro maintains GeneDx Holdings with a Buy and raises the price target from $140 to $165.
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
Reported third quarter 2025 revenues of $116.7 million with 65% year-over-year growth in exome and genome test revenue Accelerated exome and genome volume growth to 33% year-over-year Expanded adjusted gross
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
Schubert Jonckheer & Kolbe LLP reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors that the firm is investigating potential legal claims relating...
BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $140
BTIG analyst Mark Massaro maintains GeneDx Holdings with a Buy and raises the price target from $125 to $140.
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.